Live feed
Filing
SC 13G
SC 13G0000935836-24-000282·Evoke Pharma Inc
Schedule 13G ownership disclosure
EVOKE PHARMA INC
Security class unavailable · CUSIP: 30049G203
Event date: 2024-02-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 859,322
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-24-000282
- Form type
- SC 13G
- Filer
- Evoke Pharma Inc
- CIK
- CIK 1403708
- Filed
- Mar 13, 2024
- Reporting period
- Feb 09, 2024
- Description
- Schedule 13G beneficial ownership